Stock QURE UNIQURE N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus uniQure N.V.

Equities

QURE

NL0010696654

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
4.54 USD -0.44% Intraday chart for uniQure N.V. -3.61% -32.94%
Apr. 12 Uniqure N.V. Announces Paula Soteropoulos Will Not Stand for Re-Election as Non-Executive Director CI
Apr. 02 UBS Lowers UniQure's Price Target to $27 From $38, Maintains Buy Rating MT

Evolution of the average Target Price on uniQure N.V.

Price target over the last 5 years

History of analyst recommendation changes

2856c0803a62ea70f6.EWq7BXhfE_LpZoM_xpycdkF8yKVaDN5NcqcAyVB34kw.ZR_BYyAHWp-lUs9dk9rsF3kEjv0_ZrB5BtI1n2VCrwRJU9ZpCg91k6FU2g~c9a015aab392eccd942bf002db46bc91

Analyst Recommendations on uniQure N.V.

UBS Lowers UniQure's Price Target to $27 From $38, Maintains Buy Rating MT
Mizuho Securities Adjusts Price Target on uniQure to $7 From $10, Maintains Neutral Rating MT
Goldman Sachs Downgrades UniQure to Neutral From Buy, Cuts Price Target to $8 From $63 MT
RBC Cuts Price Target on UniQure to $28 From $33, Keeps Outperform Rating, Speculative Risk Qualifier MT
Kempen Downgrades UniQure to Neutral From Buy, Cuts Price Target to $18 From $28 MT
Mizuho Downgrades uniQure to Neutral From Buy, Cuts Price Target to $10 From $52 MT
Goldman Sachs Increases Price Target on uniQure to $63 From $56, Maintains Buy Rating MT
RBC Cuts Price Target on uniQure to $33 From $37, Keeps Outperform, Speculative Risk MT
Raymond James Adjusts Price Target on uniQure to $50 From $56, Maintains Outperform Rating MT
RBC Cuts Price Target on uniQure to $42 From $47, Maintains Outperform Rating, Speculative Risk Qualifier MT
RBC Lowers uniQure's Price Target to $47 From $52, Keeps Outperform Speculative Risk Rating MT
Chardan Slashes Price Target on uniQure to $27 From $45, Keeps Buy Rating MT
UBS Adjusts uniQure Price Target to $42 From $45, Maintains Buy Rating MT
Chardan Slashes Price Target on uniQure to $45 From $56 Amid a Haul on Hemgenix Royalties, Maintains Buy Rating MT
Raymond James Adjusts Price Target on uniQure to $56 From $58, Maintains Outperform Rating MT
Truist Securities Adjusts Price Target on uniQure to $55 From $65, Maintains Buy Rating MT
Credit Suisse Raises uniQure's Price Target to $55 From $51, Keeps Outperform Rating MT
UBS Adjusts uniQure Price Target to $45 From $42, Maintains Buy Rating MT
Goldman Sachs Adjusts uniQure's Price Target to $57 From $47, Keeps Buy Rating MT
UBS Adjusts Price Target on uniQure to $42 From $40, Maintains Buy Rating MT
Wells Fargo Securities Cuts uniQure N.V's Price Target to $24 From $34, Keeps Equalweight Rating MT
Chardan Research Adjusts uniQure's Price Target to $60 From $65, Reiterates Buy Rating MT
Goldman Sachs Adjusts Price Target for uniQure N.V to $51 From $59, Reiterates Buy Rating MT
Stifel Adjusts UniQure's Price Target to $37 From $66, Reiterates Buy Rating MT
Credit Suisse Lowers uniQure's Price Target to $51 from $54, Keeps Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
4.238 EUR
Average target price
18.98 EUR
Spread / Average Target
+347.95%
High Price Target
27.69 EUR
Spread / Highest target
+553.36%
Low Price Target
6.579 EUR
Spread / Lowest Target
+55.24%

Consensus detail

Consensus revision (last 18 months)

Analysts covering uniQure N.V.

UBS
Mizuho Securities
Goldman Sachs
RBC Capital Markets
Kempen
Raymond James
Chardan Research
Truist Securities
Credit Suisse
Wells Fargo Securities
Stifel Nicolaus
SVB Leerink
William Blair & Co.
Chardan
BTIG
HC Wainwright

Ratings for uniQure N.V.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. QURE Stock
  4. Consensus uniQure N.V.